EUVIMEDEUVIMED entdecken
Crossref

Hydroxyurea is associated with later onset of acute splenic sequestration crisis in sickle cell disease: Lessons from the European Sickle Cell Disease Cohort—Hydroxyurea ( ESCORT‐HU ) study

Slimane Allali iD, Frédéric Galactéros, Lena Oevermann, Giovanna Cannas, Laure Joseph, Gylna Loko, Narcisse Elenga, Malika Benkerrou, Maryse Etienne-Julan, Marie-Pierre Castex, Valentine Brousse, Mariane de Montalembert iD

American Journal of Hematology · 2024

DOI: 10.1002/ajh.27214 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Hematology, 2024. Verfasst von Slimane Allali und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Pediatrics and Pediatric Infectious Diseases, Reference Center for Sickle Cell Disease, Necker-Enfants Malades Hospital, Assist…. Hauptthemen laut MEDLINE: Hydroxyurea, Anemia, Sickle Cell. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 21 Literaturangaben. Gefördert von: Addmedica.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Acute splenic sequestration crisis (ASSC) is a potentially life‐threatening complication of sickle cell disease (SCD), typically occurring in young patients under 5 years of age, with a median age at first episode of less than 2 years. Because a beneficial effect of hydroxyurea (HU) on spleen perfusion and splenic function has been suspected, we hypothesized that HU treatment might be associated with later onset of ASSC in patients with SCD. To investigate this hypothesis, we analyzed data from the ESCORT‐HU study on a large cohort of patients with SCD receiving HU, enrolled between January 2009 and June 2017 with a follow‐up of 7309 patient‐years of observation. The median age at ASSC of the 14 patients who experienced a first episode of ASSC during the study period was 8.0 [IQR: 5.0–24.1] years. The median age at HU initiation was significantly lower in these 14 patients (4.8 [IQR: 3.3–18.7] years) compared to the 1664 patients without ASSC (19.9 [8.8–33.4] years, p = .0008). These findings suggest that ASSC may occur at an unusually late age in patients receiving HU, possibly reflecting longer preservation of spleen perfusion and function secondary to early initiation of HU. Further studies are needed to better characterize the effects of HU on spleen perfusion/function and on the occurrence of ASSC in patients with SCD ( ClinicalTrials.gov identifier: NCT02516579; European registry ENCEPP/SDPP/10565).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HydroxyureaAnemia, Sickle CellHumansChild, PreschoolChildAdolescentYoung AdultAdultSpleenAcute DiseaseRegistriesAntisickling Agents

Substanzen

HydroxyureaAntisickling Agents

Autor:innen und Institutionen

  • Department of General Pediatrics and Pediatric Infectious Diseases, Reference Center for Sickle Cell Disease, Necker-Enfants Malades Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Université Paris Cité, Paris,…
  • Department of Internal Medicine, Sickle Cell Referral Center, Henri-Mondor University Hospital-UPEC, AP-HP, Créteil, France.
  • Department of Pediatric Oncology and Hematology, Charité University Medicine, Berlin and Berlin Institute of Health, Berlin, Germany.
  • Hospices Civils de Lyon, Hôpital Edouard Herriot, Médecine Interne, Centre de Référence Constitutif: Syndromes Drépanocytaires Majeurs, Thalassémies et Autres Pathologies Rares du Globule Rouge et de l'Erythropoïèse, Ly…
  • Biotherapy Department, Necker-Enfants Malades Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Université Paris Cité, Paris, France.
  • Centre Hospitalier Universitaire de Martinique, Centre de Référence Constitutif: Syndromes Drépanocytaires Majeurs, Thalassémies et Autres Pathologies Rares du Globule Rouge et de l'Érythropoïèse des Antilles et de la G…

ORCID-Profile: Slimane Allali, Mariane de Montalembert

Förderung

  • Addmedica

Zitieren

APA

Allali, S., Galactéros, F., Oevermann, L., Cannas, G., Joseph, L., Loko, G., Elenga, N., Benkerrou, M., Etienne-Julan, M., Castex, M. P., Brousse, V., & de Montalembert, M. (2024). Hydroxyurea is associated with later onset of acute splenic sequestration crisis in sickle cell disease: Lessons from the European Sickle Cell Disease Cohort—Hydroxyurea ( ESCORT‐HU ) study. American Journal of Hematology. https://doi.org/10.1002/ajh.27214

Vancouver

Allali S, Galactéros F, Oevermann L, Cannas G, Joseph L, Loko G, et al. Hydroxyurea is associated with later onset of acute splenic sequestration crisis in sickle cell disease: Lessons from the European Sickle Cell Disease Cohort—Hydroxyurea ( ESCORT‐HU ) study. American Journal of Hematology. 2024. doi:10.1002/ajh.27214

BibTeX
@article{Allali2024,
  author = {Allali, Slimane and Galactéros, Frédéric and Oevermann, Lena and Cannas, Giovanna and Joseph, Laure and Loko, Gylna and Elenga, Narcisse and Benkerrou, Malika and Etienne-Julan, Maryse and Castex, Marie-Pierre and Brousse, Valentine and de Montalembert, Mariane},
  title = {Hydroxyurea is associated with later onset of acute splenic sequestration crisis in sickle cell disease: Lessons from the European Sickle Cell Disease Cohort—Hydroxyurea ( ESCORT‐HU ) study},
  journal = {American Journal of Hematology},
  year = {2024},
  doi = {10.1002/ajh.27214}
}
Kostenlos starten →